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Metazoans secrete an extensive array of small
proteins essential for intercellular communication,
defense, and physiologic regulation. Their synthesis
takes mere seconds, leaving minimal time for recog-
nition by the machinery for cotranslational protein
translocation into the ER. The pathway taken by
these substrates to enter the ER is not known.
Here, we show that both in vivo and in vitro, small
secretory proteins can enter the ER posttranslation-
ally via a transient cytosolic intermediate. This inter-
mediate contained calmodulin selectively bound to
the signal peptides of small secretory proteins.
Calmodulin maintained the translocation compe-
tence of small-protein precursors, precluded their
aggregation and degradation, and minimized their
inappropriate interactions with other cytosolic poly-
peptide-binding proteins. Acute inhibition of calmod-
ulin specifically impaired small-protein translocation
in vitro and in cells. These findings establish a mam-
malian posttranslational pathway for small-protein
secretion and identify an unexpected role for
calmodulin in chaperoning these precursors safely
through the cytosol.INTRODUCTION
The first step in eukaryotic protein secretion is translocation into
the endoplasmic reticulum (ER). In metazoans, this process
usually begins when the signal recognition particle (SRP) recog-
nizes the hydrophobic N-terminal signal sequence of a secretory
protein as it emerges from the ribosome (Shan andWalter, 2005).
An interaction between SRP and the SRP receptor facilitates tar-
geting of the ribosome-nascent chain complex to the ER, where
the ribosome docks onto the Sec61 protein-conducting channel
(Osborne et al., 2005). Subsequent translocation is coupled to
translation, with the polypeptide passing through the Sec61
channel as it emerges from the ribosomal exit tunnel. The signal
sequence is removed during translocation and the translocated1576 Cell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc.mature domain then traffics through the secretory pathway
for extracellular secretion. This cotranslational translocation
pathway is conserved from bacteria to mammals and is used
by most secretory and membrane proteins (Rapoport, 2007).
However, secretory proteins smaller than 100 residues
(Table S1 available online) might complete translation before
efficient cotranslational targeting (Goder et al., 2000; Zimmer-
mann and Mollay, 1986; Zimmermann et al., 1990). This is due
to a limited amount of time between when the signal sequence
is available for SRP recognition and when the termination codon
is reached. Whether such short proteins can access the cotrans-
lational pathway therefore depends on whether this time window
is sufficient for SRP recognition, targeting to its receptor, transfer
to the Sec61 translocon, and insertion into the channel. If this
window is too short, then small proteins would be released into
the cytosol and need to enter the ER posttranslationally,
a process that is poorly understood in metazoans.
Thus, a decisive question in understanding short protein
biosynthesis is whether targeting can reasonably occur during
its synthesis. Direct estimates of targeting kinetics in vivo
suggest that an average of ten seconds is needed to target
even a highly robust SRP-dependent signal (Goder et al.,
2000). This means that after a signal sequence first emerges
from the ribosome at60 residues of synthesis (Figure S1A), tar-
geting may not occur for another 60 residues (assuming trans-
lation at 6 residues/sec). A significant proportion of proteins
shorter than120 residues would therefore terminate translation
before they are targeted. While selective mRNA localization or
exceptionally strong translational arrest could conceivably over-
come these temporal constraints (Figure S1B), these potential
mechanisms are poorly characterized. Thus, short precursors
may well need to use posttranslational translocation to enter
the ER efficiently.
Posttranslational ER translocation has been most extensively
studied in yeast (Panzner et al., 1995b), where the pathway is
utilized by secretory proteins containing modestly hydrophobic
signal sequences that cannot engage SRP effectively (Ng
et al., 1996). In this pathway, it is thought that general cytosolic
chaperones, most notably of the Hsp70 family, interact with
and maintain translocation competence of fully-synthesized
substrates in the cytosol (Chirico et al., 1988; Deshaies et al.,
1988). Upon release from the chaperones, substrates engage
the heptameric Sec complex at the ER. This translocon is
composed of the Sec61 complex associated with the Sec62/63/
71/72 complex (Deshaies et al., 1991; Panzner et al., 1995a).
Substrates that enter the Sec translocon are made accessible
to lumenal Kar2 (an Hsp70 family member), which, via cycles
of ATPase-driven binding and release, ‘‘ratchets’’ the polypep-
tide across the membrane (Brodsky and Schekman, 1993;
Matlack et al., 1999; Panzner et al., 1995a). Thus, the general
paradigm is one of substrate chaperoning in the cytosol,
engagement of amembrane-bound channel, and biased translo-
cation via a lumenal polypeptide-binding protein.
Although all of the components in this pathway are conserved
in mammals, such posttranslational translocation has not been
studied extensively. Notably, classical yeast posttranslational
substrates, such as prepro-a-factor, can only translocate co-
translationally across mammalian ER membranes (Garcia and
Walter, 1988). It was therefore surmised that in higher eukary-
otes, the SRP-dependent cotranslational pathway predomi-
nantes and has evolved to accommodate a wider range of
substrates than in yeast. The main posttranslational models
analyzed thus far in mammalian systems have been short
secreted proteins (Schlenstedt and Zimmermann, 1987; Schlen-
stedt et al., 1992; Zimmermann and Mollay, 1986). While they
were observed to translocate posttranslationally in vitro, the
cellular machinery andmechanisms involved have been unclear.
Here, we demonstrate that both in vivo and in vitro, a substantial
proportion of short secretory proteins normally utilize posttrans-
lational translocation to enter the ER. Mechanistic analysis of
this pathway in vitro revealed a conceptually similar logic to
the yeast posttranslational system. However, we discovered
an unexpected function for calmodulin in recognizing short
protein precursors and chaperoning them through the cytosol.
Remarkably, calmodulin’s role in protecting short proteins from
irreversible off-pathway fates such as ubiquitination and aggre-
gation could not be fully compensated by other cytosolic
chaperones.
RESULTS AND DISCUSSION
Development of an Assay to Detect Posttranslational
Translocation
To determine whether posttranslational translocation occurs in
mammalian cells under physiologically normal conditions, we
developed an assay to detect a putative cytosolic translocation
intermediate with high specificity and sensitivity. To do this,
we determined whether a 15-residue biotin acceptor epitope
(BioTag) near the C terminus of a short protein was accessible
to cytosolic biotin ligase (BirA) before its translocation into the
ER (Figure 1A). Because the BioTag epitope would be deep
inside the ribosome when the termination codon is reached,
cotranslational (i.e., ribosome-coupled) translocation would
preclude its access to BirA. By contrast, a biotinylated signal-
cleaved product would be a signature of posttranslational trans-
location that necessarily involved a BirA-accessible cytosolic
intermediate.
Our model short protein was Cecropin A (CecA), a secreted
antimicrobial peptide derived from a 64-residue precursor.
Prolactin (Prl) served as a well-established cotranslationally
translocated model. Each protein was modified to contain aCBioTag-HA epitope (Figure 1B) and the experimental strategy
was characterized in vitro. When synthesized in rabbit reticulo-
cyte lysate (RRL), the BioTagged version of CecA could be
site-specifically biotinylated by BirA as evidenced by its pull-
downwith immobilized avidin (Figure 1C, downward arrowhead).
Biotinylation was dependent on both the BioTag and BirA.
When CecA translation reactions were incubated with ER-
derived rough microsomes (RMs), CecA was translocated into
the lumen as judged by both signal sequence cleavage and
protease protection (Figure 1D). Biotinylated CecA was translo-
cated comparably to nonbiotinylated CecA (Figure 1E, upward
arrowhead), illustrating that the small biotin moiety does not
preclude translocation. Cytosolic BirA could not access the
substrate after translocation into the ER (Emerman et al., 2010;
data not shown), confirming that biotinylation is cytosol-specific.
A similar analysis of BioTagged Prl showed that in the cytosol,
it was biotinylated in a BirA-dependent manner (Figure 1F,
downward arrowhead). Inclusion of RMs during Prl translation
resulted in its cotranslational translocation into the lumen, as
evidence by its signal cleavage. However, inclusion of BirA
during Prl translocation resulted in biotinylation of only the non-
translocated population (Figure 1F). Thus, when the ribosome
is coupled to the translocon during translocation, the nascent
chain is not accessible to BirA in the cytosol. Collectively, these
results establish a minimally perturbing, orthogonal, and site-
specific modification that can be used to ‘mark’ a putative
cytosolic intermediate without precluding its subsequent
translocation.
Posttranslational Translocation in Mammalian Cells
The biotinylation assay was imported into mammalian cells and
the behavior of CecA was analyzed. In pulse-labeled HeLa cells,
a signal-cleaved and biotinylated form of BioTagged CecA was
observed (Figure 1G; upward arrowhead). This product was
not released by selective plasma membrane permeabilization
with digitonin (Figure S1C), confirming its noncytosolic location.
CecA had therefore entered the ER (i.e., was signal cleaved),
after having been exposed to the cytosol (i.e., was biotinylated).
Biotinylation required BirA and was observed in other cell
types (Figure S1D). In contrast, BioTagged Prl was efficiently
translocated, but not biotinylated (Figure 1H), as expected for
a cotranslationally translocated protein. Thus, CecA can enter
the mammalian secretory pathway posttranslationally via a
cytosolic intermediate.
Signal sequence swapping experiments showed that both
length and signal sequence features influence access to post-
translational translocation. The Prl signal sequence fused to
the CecA mature domain (Prl-CecA) supported translocation
(as judged by signal cleavage), but little if any of the translocated
product was biotinylated (Figure 1G and Figures S1D and S1E).
When the proteasome was inhibited, biotinylated Prl-CecA
precursor was detected (Figure 1G and Figure S1E). Thus, the
highly efficient cotranslational signal sequence from Prl cannot
fully overcome the short kinetic window for SRP-mediated
targeting of a small protein. However, even when Prl-CecA
precursor was prevented from degradation, biotinylated signal-
cleaved protein was not observed, suggesting that Prl-CecA is
not an efficient posttranslational translocation substrate.ell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc. 1577
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Figure 1. Small Proteins Enter the Mammalian ER Posttranslationally
(A) Experimental strategy to discriminate ribosome-coupled cotranslational translocation (left) from posttranslational translocation (right). A biotin ligase (BirA) can
add biotin (star) to an acceptor sequence (red) only if it is exposed to the cytosol.
(B) Diagram of constructs used for translocation assays. The C-terminal tag replaces a segment of the substrate, rather than adding to the end.
(C) CecA without or with the BioTag sequence was translated in vitro in the absence or presence of recombinant BirA. The samples were either analyzed directly,
or after anti-HA immunoprecipitation (IP) or avidin pulldown (PD). Arrowhead is biotinylated product.
(D) CecA was synthesized in native rabbit reticulocyte lysate (N-RRL) and posttranslationally incubated with either buffer, liposomes (Lipo.), or ER-derived rough
microsomes (RMs). The samples were then analyzed directly or digested with proteinase K (PK) in the absence or presence of detergent (det.). The PK-digested
samples were immunoprecipitated to recover the CecA prior to analysis. Precursor (pre) and signal-cleaved (s.c.) products are indicated.
(E) CecA was synthesized in N-RRL in the absence or presence of BirA and posttranslationally incubated with RMs. The samples were either analyzed directly, or
after anti-HA IP or avidin PD. Arrowhead indicates biotinylated translocated product.
(F) BioTagged Prl was translated in the absence or presence of recombinant BirA and/or RMs and analyzed directly or subjected to anti-HA IP or avidin PD.
(G andH) BioTagged constructs were coexpressedwithout or with BirA in HeLa cells, pulse labeled for 1 hr, and subjected to anti-HA IP or avidin PD. Proteasome
inhibitor (MG132) was included during the labeling where indicated. Yellow arrowheads show biotinylated translocated product. Asterisk indicates a nonspecific
product.
See also Figure S1.The CecA signal sequence fused to the Prl mature domain
(CecA-Prl) was also translocated, but none of the signal-cleaved
product was observed to be biotinylated (Figure 1H). Bio-
tinylated CecA-Prl precursor was detected with proteasome1578 Cell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc.inhibition, indicating that it is capable of being biotinylated
in the cytosol. Thus, both Prl-CecA and CecA-Prl primarily
enter the ER cotranslationally, with cytosolically released pre-
cursor being degraded by the proteasome instead of being
translocated posttranslationally. Posttranslational translocation
is therefore neither solely encoded in the signal sequence, nor
simply a consequence of short precursors. Instead, CecA has
evolved a signal sequence that, while sub-optimal for the
cotranslational pathway, allows its short passenger to avoid
cytosolic quality control (Figure S1E) and engage a yet unchar-
acterized but specific posttranslational translocation pathway.
Comparing the relative amounts of biotinylated precursor and
translocated product (Figure 1G and Figure S1E), we estimate
that at least 35% of CecA translocates posttranslationally in
mammalian cells. This is probably an underestimate, since
biotinylation is not likely to be 100% efficient given the transient
nature of the cytosolically accessible intermediate. Thus, in vivo
under normal physiological conditions, posttranslational trans-
location is a substantial mechanism for small-protein entry into
the ER.
Reconstitution of Posttranslational Translocation
In Vitro
To mechanistically dissect this posttranslational translocation
pathway, we studied the process in a reconstituted mammalian
in vitro system. Epitope-tagged CecA precursor was synthe-
sized in RRL, further translation was prevented by either
removing ribosomes or adding RNase, and the reaction was
posttranslationally incubated with RMs. Translocation was as-
sayed by signal sequence cleavage and protease protection
assays, while protein interactions were detected by sucrose
gradient size fractionation and chemical crosslinking (Figure 2A).
In our initial studies, posttranslational translocation was ineffi-
cient (10%–30% at best; data not shown), similar to previous
findings (Schlenstedt et al., 1990, 1992). Size fractionation and
crosslinking studies of the translation products showed that
the substrate engaged many different cytosolic complexes of
heterogeneous size, only a subset of which were even modestly
translocation-competent (Figure 2B). Because low-level translo-
cation precluded any substantive mechanistic dissection, we
first optimized the system to improve homogeneity of functional
CecA complexes and maximize its translocation.
Among the conditions tested, a nonnucleased ‘‘native’’ RRL
(N-RRL) translation system proved superior. CecA precursor
synthesized in N-RRL was substantially more homogeneous on
sucrose gradients (Figure 2C), with nearly all of the CecA
migrating in a few fractions near the top (<60 kD) region of the
gradient (Figure 2D). Crosslinking analysis also showed much
more homogeneity, revealing a single20 kD interaction partner
(Figure 2C). Importantly, testing of these CecA-containing frac-
tions for translocation revealed markedly improved efficiency
of 60%. Two other short secretory proteins also showed
comparably homogenous migration in the same part of the
sucrose gradient, and these fractions were active in posttransla-
tional translocation (Figure S2).
With this improved system, we used the BirA-BioTag assay
system to determine if the posttranslational pathway is used
under conditions where the cotranslational pathway is available.
CecA translated in N-RRL supplemented with RMs and BirA
was observed to be efficiently translocated (Figure 2E). Avidin
pulldowns revealed that the translocated population was bio-
tinylated, indicating that the BioTag was accessible to cytosolicCBirA before translocation. Because the BioTag is near the C
terminus of CecA, we can further conclude that CecA must
have terminated translation and emerged from the ribosome
before its translocation. Consistent with this conclusion, inacti-
vation of the cotranslational pathway by mild trypsin digestion
of RMs had no effect on CecA translocation (data not shown).
Additional experiments testing Prl-CecA and CecA-Prl in
N-RRL confirmed that posttranslational translocation is both
length and signal sequence dependent (data not shown), exactly
as observed in vivo. Thus, CecA utilizes posttranslational
translocation to enter the microsome lumen even when the
cotranslational pathway is available. The N-RRL system there-
fore recapitulates our in vivo observations in an efficient in vitro
system amenable to mechanistic manipulation.
Mapping Small-Protein Interactions during
Posttranslational Translocation
To define the main steps of small-protein translocation, we
combined temporal staging of the translocation reaction with
general and site-specific crosslinking. In the cytosol, chemical
crosslinking in N-RRL had revealed that CecA precursor associ-
ated almost exclusively with a 20 kD protein (p20) (Figure 2C).
Upon addition of RMs, the p20 interaction was lost concomitant
with substrate translocation (Figure 3A). CecA crosslinking after
translocation revealed a major 60 kD partner (Figure 3A) that
fractionated with RMs in sedimentation assays (Figure 3B).
This crosslink was not observedwhen reconstituted RMs lacking
lumenal proteins (LD-RMs) were used (Figure 3C), suggesting
that p60 is a lumenal chaperone. We tested several candidates
in immunoprecipitation experiments and found p60 to be PDI
(Figure 3D). Photo-crosslinking with single probes incorporated
into CecA confirmed that the PDI interaction is direct and selec-
tive to the mature domain (data not shown).
Translocation assays using LD-RMs resulted in signal-
cleavage but not protease protection of CecA (Figure 3E). Similar
results were obtained when high pH extraction was used to
remove lumenal proteins (data not shown). In addition, while
signal-cleaved CecA normally cosediments with intact RMs,
signal-cleaved CecA produced with LD-RMs was cytosolic
(data not shown). This suggests that in addition to interacting
with translocated CecA, lumenal proteins are functionally neces-
sary to complete CecA translocation into the ER lumen. This is
similar to other translocation systems where lumenal proteins
are thought to bias substrate transport at a late stage of translo-
cation (Brodsky and Schekman, 1993; Nicchitta and Blobel,
1993; Panzner et al., 1995).
Thus, a cytosolic p20 interaction is converted to a PDI inter-
action in the ER lumen, presumably separated by the decisive
translocation step across the membrane. This suggests that
the mammalian small-protein translocation pathway might be
conceptually analogous to posttranslational translocation in
yeast, where translocation through the Sec61 channel is flanked
by interactions with cytosolic and lumenal chaperones. It is
therefore possible that CecA translocation could also involve
the Sec61 complex given its high conservation (Rapoport,
2007). Consistent with this idea, we observed partial inhibition
of CecA translocation with either a Sec61 inhibitor or competition
with ribosomes translating a cotranslational Sec61 substrateell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc. 1579
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Figure 2. In Vitro Reconstitution of Small-Protein Posttranslational Translocation
(A) Schematic diagram of translocation and crosslinking assays used in this study.
(B and C) CecA tagged with a 3F4 epitope was translated in either conventional nuclease treated RRL (B) or nonnucleased ‘‘native’’ RRL (N-RRL) (C) and
separated into 11 fractions on a 5%–25% sucrose gradient. Each fraction was analyzed directly (Total), after amine-reactive chemical crosslinking (DSS XL),
incubated with rough microsomes (RMs), and/or treated with proteinase K (PK) as indicated. Some samples were subject to immunopreciptation (IP) before
analysis. The positions of precursor and signal-cleaved products are shown. A prominent crosslink to a 20 kD protein observed in N-RRL is indicated (x p20).
Asterisks indicate background bands resulting from translation of endogenous mRNAs in N-RRL.
(D) Profiles of CecA migration on 5%–25% sucrose gradients when analyzed from RRL (red) versus N-RRL (blue).
(E) CecA was translated in BirA-containing N-RRL in the absence or presence of RMs. The samples were either analyzed directly, or after anti-HA IP or avidin PD
as indicated. Note that signal-cleaved CecA is biotinylated, indicating its posttranslational translocation. The reduced recovery in the avidin PD samples is due to
competing free biotin in the N-RRL.
See also Figure S2.
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Figure 3. Analysis of Small-Protein Interactions at Different Stages
of Translocation
(A) Crosslinking reactions (using the amine-reactive agent DSS) of CecA
translations after incubation with buffer, liposomes, or RMs. The major
crosslinks to p20 in the cytosol and p60 in the membrane are indicated. All
samples are immunoprecipitations with anti-3F4 to recover CecA.
(B) Crosslinking reactions of CecA after incubation with either liposomes or
RMs as in panel A were subjected to centrifugation to separate the vesicle
pellet (P) from cytosolic supernatant (S). Note that the p20 crosslink is cyto-
solic, while p60 is in the membrane fraction. Asterisks are endogenous retic-
ulocyte proteins.
(C) CecA translations were incubated with either RMs or LD-RMs (RMs
depleted of lumenal proteins), and subjected to crosslinking.
(D) CecA crosslinking reactions were subjected to IPs with antibodies against
the substrate (CecA), PDI, or an irrelevant antibody (cont.).
(E) CecA translocation reactions with either RMs or LD-RMs were analyzed by
a protease protection assay.(unpublished results). Future studies will be needed to investi-
gate this possibility and rigorously analyze the membrane and
lumenal steps in the CecA pathway. For the remainder of this
study, we focus on the poorly characterized p20-substrate
complex.
Identification of p20 as Calmodulin
In addition to CecA, p20 was the major crosslinking partner of
other short secretory proteins, but not of longer secretoryCproteins (Figure S2 and data not shown). Furthermore, this inter-
action was lost upon translocation into RMs and was signal
sequence specific since mutating hydrophobic residues in the
CecA signal to charged residues prevented p20 association
(Figure 4A). Importantly, the p20 interaction with CecA was
observed to be equally efficient even when CecA was translated
at 10-fold lower levels (data not shown). This illustrated that
p20 was not a ‘secondary’ interaction partner seen only after
saturating another factor. Thus, for multiple short proteins, p20
is a major and transient signal sequence-dependent interaction
partner in the cytosol.
Affinity purification of CecA precursor from large-scale trans-
lation reactions copurified p20 in a signal-dependent manner,
andmassmapping subsequently identified p20 to be calmodulin
(CaM) (Figure 4B). Immunoblotting of affinity-purified CecA and
immunoprecipitation of CecA crosslinking reactions confirmed
that CaM is the primary signal sequence-specific interacting
partner in the cytosol (Figures 4B and 4C). CaM is an abundant,
ubiquitously expressed, and highly conserved protein capable of
binding short 7–15 residue peptides of tremendous sequence
diversity (O’Neil and DeGrado, 1990). This promiscuity of CaM
is facilitated by a substrate-binding site rich in methionine
residues, whose hydrophobic flexible side chains can accom-
modate widely variable hydrophobic targets. A similar methio-
nine-rich binding pocket is seen in the signal sequence binding
domain of SRP (Figures S3A–S3C) (Keenan et al., 1998) and
the transmembrane domain binding region of Get3 (Mateja
et al., 2009). This suggested that CaM can bind directly to the
signal sequences of small proteins, a hypothesis validated
by site-specific photo-crosslinking experiments (Figure 4D).
Indeed, CaM was previously observed to bind isolated signal
sequences or fragments (Martoglio et al., 1997), although the
relevance of this finding was not clear. Thus, CaM would appear
to be amajor signal sequence binding protein for small secretory
proteins released into the cytosol.
CaM Requires Physiologic [Ca2+] for Signal Sequence
Interaction
Why did our initial crosslinking experiments in RRL fail to reveal
CaM interactions? The answer proved to be inhibition of CaM
binding to small-protein substrates by exogenously added
EGTA. RRL translation systems are typically treated with a
Ca2+-dependent nuclease to remove endogenous mRNAs,
followed by addition of 2 mM EGTA to inactivate the nuclease
(Pelham and Jackson, 1976). This chelates free Ca2+, which
has four binding sites on CaM, and influences its ability to bind
many of its substrates. By contrast, the nonnucleased N-RRL
system lacks EGTA, and therefore contains endogenously
derived cytosolic Ca2+. This suggested that the key feature of
N-RRL was the absence of EGTA. Indeed, standard RRL can
be ‘rescued’ in its activity by fractionation to remove the
nuclease and EGTA (Figure S3D). Like N-RRL (Figure 2C), this
fractionated RRL (Fr-RRL) shows homogeneous substrate
complexes, efficient CaM interaction, and improved CecA
translocation (Figure S3E). Addition of EGTA (independent of
nuclease) to either N-RRL or Fr-RRL (Figure 4E and data not
shown) inhibited substrate interaction with CaM and decreased
translocation efficiency (Figure 4F). Similar results were seen forell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc. 1581
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Figure 4. Calmodulin Interacts with Small-Protein
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(A) Two hydrophobic residues in the CecA signal
sequence were mutated to argininies (FV-RR) and tested
for interaction with p20 by crosslinking in N-RRL. The
bottom panel shows the results of translocation assays
using RMs.
(B) Large-scale translations of CecA or a control reaction
were affinity purified via the 3F4 tag on CecA and analyzed
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See also Figure S3.two other small proteins (data not shown). Thus, efficient post-
translational translocation and the CaM interaction were previ-
ously obscured from discovery by the long-standing practice
of treating translation systems with a Ca2+-activated nuclease.
Although the precise relationship between Ca2+ binding to the
four potential sites of CaM and its activity in signal sequence
recognition remains to be fully characterized, CaM interaction
and translocation activity were robust at a range of Ca2+ concen-
trations that encompasses the physiologic cytosolic Ca2+ levels
found in N-RRL. However, either Ca2+ chelation with > 10 mM
EGTA or excess Ca2+ > 10 mM resulted in reduced CecA trans-
location (Figure 4F). Crosslinking analysis showed that with
EGTA, CaM is unable to interact with translocation substrates,
whereas excessively high Ca2+ concentrations preclude efficient
CaM release from translocation substrates when RMs were
added (Figure 4G). These experiments illustrate that unlike
a canonical CaM interaction that is only induced upon Ca2+ influx1582 Cell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc.into the cytosol, CaM binding and release from
signal sequences is fully operational at basal
cytosolic Ca2+ concentration. Such a ‘constitu-
tive’ activity was important in postulating a
physiologic role in translocation, sinceour in vivo
studies were performed under normal condi-
tions where cytosolic [Ca2+] would be 10–
100 nM (Carafoli, 1987). Thus, although CaM
would seem to be an unlikely component of
a constitutive cellular pathway, its ability to
operate at widely ranging [Ca2+], signal se-quence selectivity, ubiquity, abundance, and flexible nature of
its hydrophobic binding site all support a direct functional role
in posttranslational translocation.
Calmodulin Is Required for Efficient Posttranslational
Translocation
To directly test this, we selectively depleted CaM from N-RRL by
passing the lysate over a resin of immobilized CaM binding
peptide (Means et al., 1991; Figure 5A). Depletion was better
than 90% as judged by both immunoblotting and undetectable
CaM-CecA crosslinks (Figures 5A and 5B). Relative to mock-
depleted lysate, CaM-depleted lysates were selectively dimin-
ished in posttranslational CecA translocation with no discernable
effect on cotranslational Prl translocation (Figures 5C and 5D).
This deficiency was fully rescued by adding back physiologic
levels of recombinant CaM, which interacted effectively with
small substrates (Figure 5B). Importantly, the levels of other
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(A) N-RRL was passed over a GST resin (control) or GST-
calmodulin binding peptide (CBP) resin (ΔCaM). The ΔCaM
lysate was complemented with HA-tagged recombinant
CaM (rCaM) purified from E. coli. Immunoblots for CaM
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(B) CaM depletion specifically impairs CecA interaction
with CaM by crosslinking (left panel). After incubation with
RMs, CecA produced in the absence of CaM does not
crosslinkwith PDI (right panel). Both effects are rescued by
rCaM.
(C) Posttranslational translocation of CecA is impaired by
CaM depletion and restored by rCaM. Hb is endogenous
hemoglobin.
(D) CaM depletion does not affect Prl cotranslational
translocation.
(E) HeLa cells expressing CecA were pulse labeled without
or with CaM inhibitors, and the relative proportions of
precursor and signal-cleaved forms of CecA quantified.
See also Figure S4.cytosolic chaperones, such as Hsp70, were unchanged after
CaM depletion (data not shown). Furthermore, CecA transloca-
tion was reduced in CaM depleted lysates even when RMs
were included cotranslationally (Figure S4A), showing that
neither cytosolic chaperones nor the cotranslational pathway
can fully replace CaM’s role.
To examine the importance of CaM in vivo, we used two inde-
pendent membrane-permeable CaM inhibitors, E6 Berbamine
and Ophiobolin A. In vitro studies verified that both inhibit CaM
binding to CecA (data not shown). When applied to HeLa cells,
both inhibitors reduced CecA translocation as judged by the
relative ratio of precursor to signal-cleaved forms recovered
from pulse-labeled cells (Figure 5E). As expected, neither inhib-
itor had an effect on Prl translocation (Figure S4B). Because the
inhibitors were applied acutely during the labeling period, poten-
tial indirect effects were minimized. Thus, CecA apparently
cannot effectively utilize either the SRP-dependent cotransla-
tional pathway or other chaperones when CaM is inhibited
in vivo. This suggests that a substantial proportion of CecA
follows the CaM-dependent posttranslational pathway.
Calmodulin Maintains Translocation Competence
of Small Proteins
To understand the mechanism by which CaM facilitates post-
translational translocation, we analyzed substrate fate in the
presence and absence of CaM. We found that for several small
secretory proteins, CaM’s role was to prevent their heteroge-
neous engagement into various high molecular weight com-
plexes, including possible aggregation (Figure 6A). This was
observed not only with EGTA (e.g., Figure 2 and Figure S2), but
also with selective CaM depletion (Figure 6A). In addition, small
proteins bound to CaM retained their translocation competence
over the course of an hour, but lost competence rapidly after
CaM dissociation with EGTA (Figure 6B). This loss of transloca-
tion competence was largely irreversible since subsequentCrestoration of Ca2+ could not effectively rescue CecA transloca-
tion (Figure 6C). Instead, substrates forcibly dissociated from
CaM made various off-pathway interactions as detected by
crosslinking. Among these interactions, one binding partner
was Bag6 (data not shown), a hydrophobic domain binding
protein that was recently shown to be a quality control factor
for degrading mislocalized proteins (Hessa et al., 2011). Indeed,
small-protein precursors are more extensively ubiquitinated
in the absence compared to presenceofCaMactivity (Figure 6D).
Thus, CaM binding to short secretory proteins protects their
hydrophobic signal sequences from terminal off-pathway
fates, thereby maintaining their solubility and translocation
competence.
Calmodulin Dissociation Is Rate Limiting for
Translocation
Since CaM does not accompany its substrate into the ER lumen,
it must release substrate for translocation to occur. A key issue is
how this release is effected. One possibility is that CaM-
substrate interactions are dynamic and that the unbound popu-
lation of substrate is able to engage the translocation machinery.
Alternatively, release might be mediated by a putative receptor
on the RMs, with CaM therefore playing the role of a specific
targeting factor. Indeed, CaM was recently found to interact
with Sec61a (Erdmann et al., 2011), which would provide an
attractive targeting mechanism for small-protein substrates. To
discriminate between these models, we analyzed the nature of
CaM-substrate interaction dynamics.
We found that in the cytosol (without RMs), the CecA-CaM
complex was dynamic. This was illustrated by the finding that
addition of recombinant GST-CaM to pre-formed CecA-CaM
complexes results in CecA equilibration between the endoge-
nous and recombinant CaM (Figure 7A). A time course using
photo-crosslinking showed that transfer from CaM to GST-
CaM began within five minutes and equilibrated with a timeell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc. 1583
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(A) Fractions from a 10%–50% sucrose gradient separa-
tion of CecA (left panels) or Prl (right panels) translated in
N-RRL not depleted or depleted of CaM. CecA engages in
high molecular weight complexes in the absence of CaM,
while endogenous Hemoglobin (Hb) and Prl are unaf-
fected.
(B) CecA-CaM complexes made in N-RRL were dissoci-
ated with 0.5 mMEGTA or preservedwith 0.1 mMCa2+ and
after various times at 32C, tested for translocation into
RMs. The quantified results from the gel are shown in the
graph.
(C) CecA translated in N-RRL was posttranslationally
subjected to two successive treatments. First, samples
were incubated without or with 0.5 mM EGTA to disrupt
CaM-CecA complexes for 15 min at 32C (1st). Second,
samples were incubated for another 15min without or with
0.5 mM Ca2+, 0.5 mM EGTA, or both (2nd). RMs were then
added to assay for translocation by either signal cleavage
(top panel) or protease protection (bottom).
(D) CecA, defensin 2, and defensin 133 were each trans-
lated in N-RRL without or with 0.5 mM EGTA. The high
molecular weight ladder seen with EGTAwas confirmed to
represent ubiquitinated species (data not shown).course that closelymatched the time course for posttranslational
translocation (Figure 7B). This suggested that the intrinsic rate
of release from CaM may be the rate-limiting event for post-
translational translocation. To test this, we asked what would
happen if substrate release from CaM were prematurely
induced. In the spontaneous release model, this should increase
the rate of substrate translocation. By contrast, a receptor-medi-
ated model would predict decreased translocation since the
substrate would no longer be bound to its targeting factor.
CaM-CecA complexes were dissociated with EGTA in the
presence of RMs and the extent of translocation at multiple
time points was assessed (Figure 7C). A clear acceleration of
rate was observed under these conditions, with translocation
being nearly complete within 5 min. Note that the converse is
also true: slowing down substrate release from CaM by
increased Ca2+ levels leads to reduced translocation (Figure 4F
and 4G). Thus, at least under the conditions of this N-RRL
in vitro system, CaM binding to substrates is dynamic, and the
rate-limiting step in translocation is determined by the kinetics
of substrate release. While a receptor does not seem to be
obligatory, it could nonetheless improve efficiency or reduce
off-pathway reactions by favoring substrate release close to its
site of translocation. This remains to be investigated, particularly
the intriguing interaction between Sec61a and CaM (Erdmann
et al., 2011).1584 Cell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc.Conclusions and Perspective
While short secreted proteins were once
considered unusual, they are now appreciated
to serve a wide range of functions in metazoans.
Notable examples include antimicrobial pep-
tides essential for innate immunity, various
toxins, hormones, chemokines, and others
whose precursors are encoded by short openreading frames (Brogden, 2005; Schluger and Rom, 1997; Table
S1). In addition, recent ribosome profiling analyses (Ingolia et al.,
2009) and bioinformatic studies (Frith et al., 2006) indicate that
many short proteins remain unannotated and that a significant
portion of these may contain hydrophobic signal sequences for
targeting to the secretory pathway. Our results provide new
mechanistic insights into how small secretory proteins enter
the mammalian ER.
We have illustrated both in vitro and in vivo that short proteins
utilize a posttranslational translocation pathway and identify
CaM as a specific chaperone that stabilizes the cytosolic inter-
mediate in this process (Figure 7D). CaM directly binds to the
hydrophobic signal sequences of short secretory proteins in
a Ca2+-regulated manner, shielding them from detrimental fates
in the aqueous cytosol, preventing their recognition by quality
control, andmaintaining their ability to translocate. This pathway
fills a niche that cannot be fully accommodated by either the
SRP-dependent cotranslational pathway or general cytosolic
chaperones. Hence, even under cotranslational translocation
conditions in vitro or in vivo, a substantial amount of translocated
CecA was derived from a cytosolic intermediate. Furthermore,
selective depletion or inhibition of CaM substantially reduced
small-protein translocation and increased off-pathway fates.
Thus, CaM-dependent translocation is a major (but perhaps
not exclusive) pathway used by small proteins.
CaM
ER
lumen
degr.
aggr.
cotransl.
transloc.
Time: 0 5 10 15 30
+EGTA
-EGTA
EGTA 0-30’
GelRM
s.c.
pre
s.c.
pre
0 0 0.5 1 2.5 5 10 20 30 30Time (min):
UV: - -+ + + + + + + +
- pre
- x CaM
- x GST-CaM
- pre
- x CaMNo
additions
+ GST-CaM
GST-CaM:
- pre
- x CaM
- x GST-CaM
DSS XL
A
C
B
D
0
25
50
75
100
0 10 20 30
Transfer
Translocation
%
 M
ax
im
al
Time (min)
Figure 7. Calmodulin Release Is Rate Limiting for Small-Protein Translocation
(A) CecA translated in N-RRL was posttranslationally incubated without or with different concentrations of recombinant GST-CaM for 30 min at 32C and
subjected to crosslinking (DSS XL). The positions of crosslinks to CaM and GST-CaM are indicated.
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(C) CecA-CaM complexes made in N-RRLwere dissociated with 0.5 mMEGTA in the presence of RMs, incubated for varying times, and analyzed by SDS-PAGE.
Translocation occurs within 5 min after EGTA dissociation but is normally slower at endogenous Ca2+ levels.
(D) Working model. Small proteins have poor access to cotranslational translocation, but instead interact dynamically with CaM in the cytosol. This prevents
degradation and aggregation, while still allowing translocation to occur upon CaM release. See Table S1 for examples of small secretory proteins that may use
this pathway.The observation that CaM depletion (or inhibition) could not
be readily compensated by other abundant polypeptide binding
proteins was unexpected. This differs from yeast, where multiple
chaperones, most notably of the Hsp70 family, interact with
and maintain translocation competence of substrates. The
mammalian orthologs of these chaperones are clearly functional
since a yeast substrate (prepro-a-factor) synthesized in nucle-
ased RRL can interact with them and posttranslationally
translocate into yeast RMs (Plath and Rapoport, 2000; Rothblatt
et al., 1987). So why are the mammalian orthologs of these
chaperones unable to fulfill the same function for small proteins?
One reason might be the need for more complete shielding ofCthe hydrophobic signal sequence to prevent aggregation.
Indeed, substrates engage in large translocation-incompetent
complexes in the absence of CaM, despite the availability of
the full complement of cytosolic chaperones. This might not be
a problem in yeast where posttranslational substrates typically
have signal sequences of lower hydrophobicity (Ng et al.,
1996), and any aggregation can be reversed by Hsp104, a fungal
specific chaperone (Doyle and Wickner, 2009).
In addition, metazoans often couple their chaperone systems
more directly to ubiquitination pathways (Hessa et al., 2011;
McConough and Patterson, 2003). Hence, CaM can maintain
its substrates in a translocation competent state without theell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc. 1585
risk of rapid degradation. Consistent with this idea, small-protein
substrates are ubiquitinated in vitro in the absence of CaM, and
CaM-independent precursors (but not CaM-dependent ones)
are rapidly degraded in a proteasome-dependent pathway
in vivo. Thus, while general cytosolic chaperones can maintain
translocation competence of small proteins in principle, CaM’s
signal sequence selectivity, ability to completely wrap around
and shield its substrate, and lack of coupling to ubiquitination
machinery all afford advantages.
Finally, high volume secretion of small proteins, such as insulin
and beta-defensin-2, are often accompanied by significant
changes in intracellular Ca2+ levels that directly affect secretion
in multiple ways including transcription, translation, and traf-
ficking (German et al., 1990; Krisanaprakornkit et al., 2003;
Pernet et al., 2003). This imposes rapid and very large changes
in translocation load without sufficient time to increase translo-
con abundance. It is attractive to speculate that the ability of
CaM to efficiently maintain translocation competence, particu-
larly under high Ca2+ conditions, may buffer against temporary
increases in small-protein production without having to degrade
the excess. Given that CaM is the target of much regulation, one
might also anticipate that small-protein secretion could be
responsive to changing needs and extracellular cues.EXPERIMENTAL PROCEDURES
Reagents and Standard Methods
All plasmid constructs have been described or are minor modifications to
existing constructs produced using standardmethods (Stefanovic and Hegde,
2007; Emerman et al., 2010). CaM antibody was obtained from Abcam. All
other antibodies, in vitro translations and biotinylation, sucrose gradients,
chemical crosslinking, photocrosslinking, immunoblotting, affinity purification,
immunoprecipitations, and avidin pulldowns have been described (Stefanovic
and Hegde, 2007; Emerman et al., 2010; Hessa et al., 2011; Fons et al., 2003;
Do et al., 32). Culture, transfection, and pulse-chase analysis of HeLa and
293T were as before (Emerman et al., 2010). Recombinant His-tagged and
GST-tagged CaM, His-tagged BirA, and GST-tagged CaM binding peptide
were purified from E. coli using standard procedures. Details are provided in
the Extended Experimental Procedures of the Supplemental Information.
In Vivo Biotinylation
HeLa or HEK293T cells seeded in 6-well dishes were cotransfected with
plasmids encoding substrate and BirA in a 4:1 ratio using Lipofectamine
2000 (Invitrogen). 16 hr after transfection, cells were radiolabeled with
150 mCi translabel for 1 hr (Emerman et al., 2010), harvested in 1% SDS,
0.1 M Tris, pH 8 and immediately boiled to fully solubilize all proteins and
destroy all enzymatic activities. Pulldowns and immunoprecipitations were
performed as described (Emerman et al., 2010) on samples diluted 10-fold
in ice cold IP buffer (1% Triton X-100, 50 mM HEPES, (pH 7.4), 100 mM
NaCl). For proteasome inhibition and CaM inhibition, 10 mM MG132 and/or
inhibitors were added during labeling.
Translation Extracts
Fr-RRL has been described (Hessa et al., 2011; see Extended Experimental
Procedures). N-RRL was made by reconstituting native RRL that had not
been treated with hemin or nuclease into a translation system using the
same final concentrations of components as the RRL and Fr-RRL translation
systems (Hessa et al., 2011). CaM-depleted translation extract was produced
by passing native RRL over GST-tagged CaM binding peptide immobilized on
a glutathione sepharose column and reconstituting the flow-through into a
translation system. Detailed protocols are provided in Extended Experimental
Procedures.1586 Cell 147, 1576–1588, December 23, 2011 ª2011 Elsevier Inc.In Vitro Translation and Translocation
In vitro transcription and translation in RRL and Fr-RRL in the presence of
35S-methionine were as described before for 30 min at 32C (Stefanovic and
Hegde, 2007; Hessa et al., 2011; Sharma et al., 2010). Translation in N-RRL
was the same as in RRL except that the translation extract was made with
a completely ‘native’ RRL (i.e., nonnucleased and nonhemin treated). Final
concentrations of all other additives remain the same. Thus, N-RRL contains
the endogenous level of cytosolic Ca2+ derived from the reticulocyte cytosol,
and any trace amounts contributed by the water and other shelf chemicals.
Cotranslational translocation assays into RMs have been described previously
(Fons et al., 2003). For posttranslational translocation assays, translation was
terminated by either adding 10 mg/ml RNase A and/or by removing of ribo-
somes by ultracentrifugation (70,000 rpm in the TLA120.1 rotor (Beckman)
for 30 min at 4C). Translocation was initiated by adding RMs (derived from
either canine or porcine pancreas; Walter and Blobel, 1983). The addition of
recombinant proteins and calcium and EGTAmanipulationswere as described
in the individual figure legends. Unless otherwise noted, translocation assays
were for 30min at 32C, except for those shown in Figure 7C, which were con-
ducted at 37C. Protease protection assay for translocated products was as
before (Stefanovic and Hegde, 2007; Fons et al., 2003). For immunoprecipita-
tions or pulldowns, samples were first denatured by boiling to 100C in 1%
SDS, 0.1 M Tris, pH 8, then treated as described above for IPs or pulldowns
from cultured cells. Translocation efficiencies were quantified with either
Image J or by phosphorimaging using a Typhoon scanner. All band intensities
were subtracted of background intensities and normalized for the number of
methionines expected to be in the products.
Sucrose Gradients, Crosslinking, and Translocation
In most experiments, 200 ml translation reactions were layered on a 2 ml 5%–
25% sucrose gradients in physiologic salt buffer (PSB: 50 mM Hepes, [pH
7.4], 100 mM KAc, 2 mM MgAc2) and centrifuged for 5 hr at 55,000 rpm at
4C in the TLS-55 rotor (Beckman). Eleven 200 ml fractions were then removed
from the top. For translocation assays of sucrose gradient fractions, RMs were
added (composing one tenth of the reaction volume), the reaction supple-
mented with an energy-regenerating system (1 mM ATP, 1 mM GTP,
10 mM Creatine phosphate, 40 mg/ml Creatine Kinase) and 1 mM DTT, and
incubated for 30 min at 32C. The remaining analysis was as above. Chemical
crosslinking experiments of sucrose gradient fractions were performed with
250 mM DSS at room temperature for 30 min, quenched with 100 mM Tris,
and samples were then subject to direct analysis or immunoprecipitation.
For crosslinking of RRL, or N-RRL translation reactions, the samples were
first diluted 10-fold in PSB (to dilute primary amines) before adding crosslinker
as above. Fr-RRL was crosslinked directly since its buffer composition was
known (see above) to lack primary amines. Photocrosslinking using benzo-
phenone-modified or 4,4-azipentanoyl-modified lysyl-tRNA (from tRNA
Probes) was as before (Do et al., 1996; Krieg et al., 1986), except Fr-RRL
was used for the translation and the suppressor tRNA was included in the
translation reaction at a final concentration of 1 mM. Both probes gave similar
site-specific and crosslinking efficiency results. Crosslinking time courses
were performed by rapidly freezing samples in liquid nitrogen at the indicated
time points and UV irradiating on dry ice (Plath et al., 2004). Size fractionation
of CecA and Prl in CaM-depleted lysates were on a 10%–50% sucrose
gradient in PSB centrifuged at 55,000 rpm for 1 hr at 4C in the TLS-55 rotor,
after which 200 ml fractions were collected and analyzed directly.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
one table, and four figures and can be found with this article online at
doi:10.1016/j.cell.2011.11.048.
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